Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women`s intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle r...
Website: cutera.com



Growth: Bad revenue growth rate -4.7%, there is slowdown compared to average historical growth rates 22.4%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -23.2%. On average the margin is decreasing steadily. Gross margin is high, +45.8%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$0.12 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -59.4% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 53.6% higher than minimum and 97.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.1x by EV / Sales multiple , the company can be 6.3% overvalued

Key Financials (Download financials)

Ticker: CUTR
Share price, USD:  (+3.9%)2.12
year average price 7.77  


year start price 22.80 2023-04-29

max close price 22.80 2023-04-29

min close price 1.38 2024-04-01

current price 2.12 2024-04-27
Common stocks: 19 858 000

Dividend Yield:  0.0%
Last revenue growth (y/y):  -4.7%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  22.4%
Historical growth of EBITDA:  ---
EV / Sales: 1.2x
Margin (EBITDA LTM / Revenue): -23.2%
Fundamental value created in LTM:
Market Cap ($m): 42
Net Debt ($m): 250
EV (Enterprise Value): 292
Price to Book: -0.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-03-27Invezz

Shorts thrive as Luminar, Sunnova, and Cutera stock prices dive

2024-03-21Seeking Alpha

Cutera, Inc. (CUTR) Q4 2023 Earnings Call Transcript

2024-02-21Zacks Investment Research

3 Laser Systems Stocks to Watch in a Challenging Industry

2023-11-10Business Wire

Cutera, Inc. to Participate in Upcoming Investor Conferences

2023-11-08Seeking Alpha

Cutera, Inc. (CUTR) Q3 2023 Earnings Call Transcript

2023-10-25Business Wire

Cutera, Inc. to Announce Third Quarter Results on November 8, 2023

2023-08-08Seeking Alpha

Cutera, Inc. (CUTR) Q2 2023 Earnings Call Transcript

2023-08-08Zacks Investment Research

Cutera (CUTR) Reports Q2 Loss, Misses Revenue Estimates

2023-07-31GuruFocus

Pura Vida Investments, LLC Acquires Additional Shares in Cutera Inc

2023-07-27Reuters

Cutera taps serial dealmaker Harris as CEO, stock price surges
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol CUTR CUTR CUTR CUTR CUTR CUTR
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-21 2024-03-05 2023-08-09 2023-05-10 2023-04-07 2022-11-09
acceptedDate 2024-03-21 16:02:47 2024-03-05 16:29:37 2023-08-09 16:39:48 2023-05-10 16:59:20 2023-04-07 17:08:06 2022-11-09 16:21:43
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 50M 46M 61M 55M 67M 63M
costOfRevenue 43M 43M 33M 30M 29M 29M
grossProfit 6M 3M 28M 25M 39M 34M
grossProfitRatio 0.126 0.074 0.458 0.453 0.575 0.545
researchAndDevelopmentExpenses 5M 5M 6M 6M 5M 6M
generalAndAdministrativeExpenses 22M 17M 19M 13M 10M 11M
sellingAndMarketingExpenses 24M 26M 33M 30M 29M 26M
sellingGeneralAndAdministrativeExpenses 46M 40M 52M 42M 39M 37M
otherExpenses 0 -2M -453 000 -163 000 -593 000 0
operatingExpenses 51M 44M 58M 48M 44M 44M
costAndExpenses 94M 87M 91M 79M 73M 72M
interestIncome 2M 2M 2M 2M 2M 2M
interestExpense 4M 4M 3M 3M 2M 2M
depreciationAndAmortization 5M 5M 2M 3M 2M 539 000
ebitda -39M -36M -27M -20M -4M -9M
ebitdaratio -0.791 -0.773 -0.433 -0.371 -0.060 -0.142
operatingIncome -44M -41M -30M -24M -6M -9M
operatingIncomeRatio -0.895 -0.881 -0.482 -0.429 -0.082 -0.150
totalOtherIncomeExpensesNet -145 000 -3M -453 000 -1M -1M -2M
incomeBeforeTax -44M -44M -31M -25M -7M -11M
incomeBeforeTaxRatio -0.897 -0.949 -0.512 -0.450 -0.104 -0.180
incomeTaxExpense 769 000 167 000 326 000 272 000 764 000 827 000
netIncome -45M -44M -32M -25M -8M -12M
netIncomeRatio -0.913 -0.953 -0.517 -0.455 -0.116 -0.193
eps -2.270 -2.220 -1.590 -1.260 -0.400 -0.620
epsdiluted -2.270 -2.220 -1.590 -1.260 -0.400 -0.620
weightedAverageShsOut 20M 20M 20M 20M 20M 20M
weightedAverageShsOutDil 20M 20M 20M 20M 20M 20M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol CUTR CUTR CUTR CUTR CUTR CUTR
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-21 2024-03-05 2023-08-09 2023-05-10 2023-04-07 2022-11-09
acceptedDate 2024-03-21 16:02:47 2024-03-05 16:29:37 2023-08-09 16:39:48 2023-05-10 16:59:20 2023-04-07 17:08:06 2022-11-09 16:21:43
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 144M 180M 181M 167M 146M 46M
shortTermInvestments 0 -16 000 42M 101M 171M 205M
cashAndShortTermInvestments 144M 180M 223M 268M 317M 251M
netReceivables 43M 55M 53M 61M 46M 36M
inventory 62M 73M 69M 72M 64M 56M
otherCurrentAssets 20M 4M 25M 7000.000 24M 24M
totalCurrentAssets 268M 311M 370M 418M 451M 366M
propertyPlantEquipmentNet 47M 81M 77M 65M 53M 48M
goodwill 1M 1M 1M 1M 1M 1M
intangibleAssets 0 0 1M 0 0 0
goodwillAndIntangibleAssets 1M 1M 1M 1M 1M 1M
longTermInvestments 0 -1.000 0 0 0 0
taxAssets 579 000 528 000 547 000 577 000 590 000 626 000
otherNonCurrentAssets 38M 13M 15M 14M 15M 12M
totalNonCurrentAssets 87M 95M 94M 81M 70M 62M
otherAssets 1.000 1.000 0 0 0 0
totalAssets 355M 407M 464M 500M 521M 428M
accountPayables 20M 31M 34M 35M 34M 34M
shortTermDebt 2M 3M 3M 3M 3M 3M
taxPayables 0 5M 10M 10M 9M 6M
deferredRevenue 10M 11M 12M 12M 12M 11M
otherCurrentLiabilities 52M 46M 54M 59M 57M 51M
totalCurrentLiabilities 85M 92M 103M 109M 106M 98M
longTermDebt 419M 418M 428M 428M 428M 312M
deferredRevenueNonCurrent 1M 2M 2M 2M 2M 2M
deferredTaxLiabilitiesNonCurrent 9M 11M 0 0 0 0
otherNonCurrentLiabilities 1M 36 000 575 000 711 000 862 000 267M
totalNonCurrentLiabilities 430M 430M 430M 430M 430M 314M
otherLiabilities 1.000 0 0 0 0 0
capitalLeaseObligations 9M 11M 13M 13M 14M 14M
totalLiabilities 515M 523M 533M 539M 536M 413M
preferredStock 0 0 0 0 0 0
commonStock 20 000 20 000 20 000 20 000 20 000 20 000
retainedEarnings -291M -246M -197M -166M -141M -133M
accumulatedOtherComprehensiveIncomeLoss 0 0 4000.000 -8000.000 -94 000 -336 000
othertotalStockholdersEquity 131M 130M 128M 127M 125M 149M
totalStockholdersEquity -160M -116M -69M -39M -15M 15M
totalEquity -160M -116M -69M -39M -15M 15M
totalLiabilitiesAndStockholdersEquity 355M 407M 464M 500M 521M 428M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 355M 407M 464M 500M 521M 428M
totalInvestments 0 -16 000 42M 101M 171M 205M
totalDebt 430M 432M 430M 430M 431M 315M
netDebt 286M 252M 250M 264M 285M 269M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol CUTR CUTR CUTR CUTR CUTR CUTR
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-03-21 2024-03-05 2023-08-09 2023-05-10 2023-04-07 2022-11-09
acceptedDate 2024-03-21 16:02:47 2024-03-05 16:29:37 2023-08-09 16:39:48 2023-05-10 16:59:20 2023-04-07 17:08:06 2022-11-09 16:21:43
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome -45M -44M -32M -25M -8M -12M
depreciationAndAmortization 5M 5M 2M 1M 1M 674 000
deferredIncomeTax -51 000 19 000 30 000 13 000 36 000 72 000
stockBasedCompensation 2M 2M 2M 3M 1M 4M
changeInWorkingCapital 2M -4M -7M -19M -14M -13M
accountsReceivables 5M 276 000 -3M -7M -11M -4M
inventory 5M 2M 3M -8M -6M -11M
accountsPayables -10M -3M -336 000 -1M 537 000 6M
otherWorkingCapital 3M -4M -7M -2M 2M -4M
otherNonCashItems 15M 5M 4M 2M 2M 547 000
netCashProvidedByOperatingActivities -34M -37M -31M -37M -17M -20M
investmentsInPropertyPlantAndEquipment -3M -6M -15M -11M -9M -6M
acquisitionsNet 0 0 0 11M 23M 0
purchasesOfInvestments 0 0 0 -23M -77M -49M
salesMaturitiesOfInvestments 0 41M 60M 95M 111M 47M
otherInvestingActivites -3M 39M 0 -11M -23M 0
netCashUsedForInvestingActivites -3M 36M 45M 60M 25M -8M
debtRepayment -208 000 -149 000 -113 000 -124 000 -127 000 -108 000
commonStockIssued 0 465 000 749 000 109 000 3M 248 000
commonStockRepurchased -24 000 -87 000 -789 000 0 0 0
dividendsPaid 0 0 -40 000 0 0 0
otherFinancingActivites -24 000 -87 000 40 000 -2M 89M -2M
netCashUsedProvidedByFinancingActivities -232 000 229 000 -153 000 -2M 92M -1M
effectOfForexChangesOnCash 0 0 0 0 0 0
netChangeInCash -37M -1M 14M 21M 100M -29M
cashAtEndOfPeriod 144M 180M 181M 168M 147M 47M
cashAtBeginningOfPeriod 180M 181M 168M 147M 47M 76M
operatingCashFlow -34M -37M -31M -37M -17M -20M
capitalExpenditure -3M -6M -15M -11M -9M -6M
freeCashFlow -36M -42M -46M -48M -26M -26M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-03-21 ET (fiscal 2023 q4)
2023 q3
2023-11-08 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-28 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-10 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-03-21 20:01 ET
Cutera Announces Fourth Quarter and Full-Year 2023 Financial Results Along with 2024 Outlook
2024-03-01 13:30 ET
Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024
2024-02-08 13:00 ET
Cutera Announces the International Limited Commercial Release of AviClear® at IMCAS World Congress 2024
2024-01-09 13:00 ET
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023
2023-11-20 13:00 ET
Justera Revenue Boosts with Launching of Cutera XEO Laser Treatment and Plan to Expand
2023-11-16 23:05 ET
Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules
2023-11-16 23:00 ET
Cutera, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-Q
2023-11-13 13:30 ET
Cutera Appoints Stephana Patton as Chief Legal Officer
2023-11-10 22:07 ET
Cutera, Inc. to Participate in Upcoming Investor Conferences
2023-11-08 21:01 ET
Cutera Provides Third Quarter 2023 Business Update
2023-11-08 13:00 ET
Justera Launches Premium Laser Treatment with CUTERA XEO
2023-10-26 00:06 ET
Cutera, Inc. to Announce Third Quarter Results on November 8, 2023
2023-10-06 21:00 ET
Cutera Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
2023-10-02 12:30 ET
Cutera, Inc. Appoints Brent Hauser as President, International
2023-09-07 12:00 ET
Cutera Announces the Launch of New Skin Resurfacing and Revitalization Platform Secret DUO®
2023-09-01 22:30 ET
Cutera Reports Inducement Grants as permitted by the Nasdaq Listing Rules
2023-08-24 13:00 ET
Cutera, Inc. Appoints Jeff Jones as Chief Operating Officer
2023-08-08 20:01 ET
Cutera Announces Second Quarter 2023 Financial Results along with 2023 Outlook
2023-07-27 13:00 ET
Cutera, Inc. Appoints Taylor Harris as Chief Executive Officer
2023-07-22 00:00 ET
Cutera, Inc. to Announce Second Quarter Results on August 8, 2023
2023-07-10 13:10 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-07-04 13:20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-29 13:20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-26 13:20 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-20 13:30 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-19 12:30 ET
Cutera, Inc. to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest on Tuesday, June 20th
2023-06-15 13:03 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-15 12:30 ET
FDA Clears AviClear® as a Long-Term Treatment for Mild to Severe Acne
2023-06-12 13:30 ET
Cutera Shareholders: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action - Contact Lieff Cabraser
2023-06-06 13:30 ET
Cutera Investors: 7/24/2023 Plaintiff Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-02 17:55 ET
Cutera Investors: July 24, 2023 Filing Deadline in Securities Class Action – Contact Lieff Cabraser
2023-06-01 12:30 ET
Cutera® Celebrates One Year of Revolutionizing the Acne Market with AviClear® During Acne Awareness Month
2023-05-15 20:15 ET
Cutera Cancels Special Meeting
2023-05-12 13:00 ET
Cutera Comments on Termination of Voce Capital’s Special Meeting Proxy Solicitation
2023-05-11 20:16 ET
Voce Capital Provides Update on Cutera Special Meeting
2023-05-09 21:09 ET
Cutera Announces Agreements with Pura Vida and RTW
2023-05-09 20:01 ET
Cutera Announces First Quarter 2023 Financial Results
2023-04-25 00:30 ET
Cutera, Inc. to Announce First Quarter Results on May 9, 2023
2023-04-18 20:15 ET
Cutera Directors J. Daniel Plants and David Mowry Respond to Special Committee’s Attempt to Rewrite History
2023-04-17 12:00 ET
Cutera, Inc.’s Special Committee Updates Stockholders on Its Recent Steps to Protect Stockholder Interests
2023-04-14 12:00 ET
Cutera® Celebrates 25 Years of Excellence in Innovation
2023-04-13 20:01 ET
Cutera, Inc. to Hold Special Meeting of Stockholders
2023-04-12 21:55 ET
RTW Investments, LP Issues Statement Regarding Cutera's Special Meeting of Stockholders
2023-04-12 20:35 ET
Cutera Directors J. Daniel Plants and David Mowry Take Legal Action to Ensure Shareholders Have a Say in Composition of Cutera’s Board and Selection of its Next CEO
2023-04-12 10:00 ET
Cutera, Inc. Announces Executive Leadership and Governance Changes
2023-04-11 20:49 ET
David Mowry and J. Daniel Plants Share Letter of Support from Cutera Senior Leaders Sent to Company’s Board
2023-04-11 19:41 ET
Pura Vida Investments Calls for Cutera Board to Immediately Extend Director Nomination Deadline
2023-04-10 22:00 ET
Cutera Regains Compliance with Nasdaq Listing Rules
2023-04-10 11:35 ET
J. Daniel Plants and David Mowry Call for Special Stockholder Meeting to Reconstitute Cutera’s Board
2023-04-07 19:30 ET
Cutera, Inc. Acknowledges Receipt of Special Meeting Demand from Daniel Plants
2023-03-24 21:15 ET
Cutera Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 10-K
2023-03-14 12:00 ET
Cutera® Unveils the Reimagined truBody® Brand
2023-02-28 21:01 ET
Cutera Announces Fourth Quarter and Full-Year 2022 Financial Results along with 2023 Outlook
2023-02-15 02:15 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2022 Results on February 28, 2023
2023-01-09 13:30 ET
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2022
2022-12-08 12:00 ET
Cutera, Inc. Announces Pricing of Offering of $100 Million of Convertible Senior Notes
2022-12-07 21:01 ET
Cutera, Inc. Announces Proposed Private Offering of $100 Million of Convertible Senior Notes
2022-12-01 21:30 ET
Cutera, Inc. Provides Response to FDA Inquiry
2022-11-21 22:00 ET
Cutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare Conference
2022-11-10 22:10 ET
Cutera, Inc. to Participate in a Fireside Chat at the Stifel Healthcare 2022 Conference
2022-11-10 22:10 ET
Cutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment Conference
2022-11-07 13:01 ET
AviClear™ Now Broadly Available to US Physicians and Practitioners Upon National Launch
2022-11-03 20:01 ET
Cutera Announces Third Quarter 2022 Financial Results
2022-10-25 12:01 ET
Cutera’s AviClearTM 12-Month Clinical Data Presented at the 42nd Annual Fall Clinical Dermatology Conference
2022-10-20 21:53 ET
Cutera, Inc. to Announce Third Quarter Results on November 3, 2022
2022-09-08 12:00 ET
Cutera Announces Over 1,000 AviClear™ Acne Treatments Performed
2022-08-04 20:01 ET
Cutera Announces Second Quarter 2022 Financial Results
2022-07-28 22:39 ET
Cutera, Inc. to Announce Second Quarter Results on August 4, 2022
2022-07-13 13:00 ET
Health Canada Clears Cutera’s AviClear™
2022-06-13 12:00 ET
New Research Reveals Roughly 4 in 5 Moderate to Severe Acne Sufferers Have Missed Moments in Their Life Due to Acne
2022-05-25 07:15 ET
Cutera, Inc. Announces Pricing of Offering of $200 Million and Concurrent Private Placement of $10 Million of Convertible Senior Notes
2022-05-24 11:47 ET
Cutera, Inc. Announces Proposed Private Offering of $200 Million of Convertible Senior Notes
2022-05-10 20:01 ET
Cutera Announces Record First Quarter 2022 Revenue Results
2022-05-02 12:00 ET
Cutera’s AviClear™ Clinical Data Presented at the Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS)
2022-04-28 02:12 ET
Cutera, Inc. to Announce First Quarter Results on May 10, 2022
2022-04-20 12:00 ET
Cutera Partners with Synchrony to Provide Financing Options to Dermatology Patients for Innovative New Acne Treatment
2022-04-05 12:00 ET
Cutera Announces First Patient Treated with FDA Cleared AviClear™ Acne Device
2022-03-25 12:00 ET
FDA Clears Cutera’s AviClear™ Acne Device
2022-03-24 18:05 ET
Cutera, Inc. to Participate in the Aesthetic Device Industry Panel at the Maxim Virtual Growth Conference
2022-02-22 21:01 ET
Cutera, Inc. Announces Fourth Quarter and Full-Year 2021 Financial Results Along With 2022 Outlook
2022-01-31 23:52 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2021 Results on February 22, 2022
2021-12-13 13:59 ET
Cutera Appoints Janet Widmann and Juliane Park to Its Board of Directors
2021-12-01 16:34 ET
Cutera Launches Next Gen Rapid Muscle Sculpting with truSculpt® flex+
2021-11-23 20:20 ET
Cutera, Inc. to Participate in the Piper Sandler Virtual Healthcare Conference
2021-11-11 00:18 ET
Cutera, Inc. to Participate in a Virtual Fireside Chat at the Stifel Healthcare Conference
2021-11-03 20:01 ET
Cutera, Inc. Announces Third Quarter 2021 Financial Results; Raises Full-year Revenue Guidance
2021-10-12 22:00 ET
Cutera, Inc. to Announce Third Quarter Results on November 3, 2021
2021-09-16 23:00 ET
Cutera, Inc. to Participate in a Virtual Fireside Chat at the Cantor Fitzgerald Global Healthcare Conference
2021-08-04 20:01 ET
Cutera, Inc. Announces Second Quarter 2021 Financial Results with Record Revenue and Issues 2021 Guidance
2021-07-15 20:01 ET
CORRECTING and REPLACING Cutera, Inc. to Announce Second Quarter Results on August 4, 2021
2021-06-16 20:13 ET
Cutera Announces Renewal of Distribution Agreement with ZO Skin Health
2021-05-17 20:01 ET
Cutera Appoints Sheila Hopkins to its Board of Directors
2021-05-10 21:05 ET
Cutera to Present at the UBS Global Healthcare Conference
2021-05-05 20:04 ET
Cutera, Inc. Announces Departure of Jason Richey
2021-05-05 20:01 ET
Cutera, Inc. Announces First Quarter 2021 Financial Results
2021-04-22 00:00 ET
Cutera, Inc. to Announce First Quarter Results on May 5, 2021
2021-03-17 12:01 ET
The Spa at Nita Lake Lodge Unveils Award Winning Technologies by Cutera(R)
2021-03-05 12:01 ET
Cutera, Inc. Announces Pricing of Offering of $125 Million of Convertible Senior Notes
2021-03-03 22:05 ET
Cutera, Inc. Announces Proposed Private Offering of $125 Million of Convertible Senior Notes
2021-02-17 21:01 ET
Cutera, Inc. Announces Fourth Quarter and Full-Year 2020 Financial Results
2021-02-02 12:00 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2020 Results on February 17, 2021
2020-11-24 17:59 ET
Cutera to Participate in the Piper Sandler Virtual Healthcare Conference
2020-11-12 21:17 ET
Cutera to Participate in Two Virtual Fireside Chats at Investor Conferences in November
2020-11-04 21:01 ET
Cutera, Inc. Announces Third Quarter 2020 Financial Results
2020-10-19 16:51 ET
Power Couple Becomes First to Flex Muscles in Calgary
2020-10-15 13:16 ET
Cutera, Inc. to Announce Third Quarter Results on November 4, 2020
2020-09-10 20:01 ET
Cutera to Participate in a Virtual Fireside Chat at the Cantor Global Healthcare Conference
2020-09-01 15:08 ET
Industry Leading truSculpt® flex Launches Its Muscle in Canada
2020-08-24 15:11 ET
Cutera Reverses Aging, Unveils Powerful Technology
2020-08-07 20:01 ET
Cutera to Present at the Canaccord Genuity Growth Conference
2020-08-06 20:05 ET
Cutera Appoints Rohan Seth as Chief Financial Officer
2020-08-06 20:01 ET
Cutera, Inc. Announces Second Quarter 2020 Financial Results
2020-07-29 11:00 ET
Cutera, Inc. to Announce Second Quarter Results on August 6, 2020
2020-07-14 20:01 ET
Cutera to Participate in Maxim Group’s “Re-Engaging Medical Practices in an Era of COVID-19” Webinar
2020-05-18 20:01 ET
Cutera to Present at the UBS Global Healthcare Conference
2020-05-07 20:01 ET
Cutera, Inc. Announces First Quarter 2020 Financial Results
2020-05-04 11:05 ET
truSculpt® flex From Cutera, Inc. Wins 2020 Good Housekeeping Award
2020-04-30 20:01 ET
Cutera, Inc. to Announce First Quarter Results on May 7, 2020
2020-04-21 20:24 ET
Cutera, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriter’s Option to Purchase Additional Stock
2020-04-17 02:12 ET
Cutera, Inc. Announces Pricing of Public Offering of Common Stock
2020-04-16 20:04 ET
Cutera, Inc. Announces Proposed Public Offering of Common Stock
2020-02-26 21:10 ET
Cutera, Inc. Announces Fourth Quarter and Full-Year 2019 Financial Results
2020-02-13 21:41 ET
Cutera, Inc. to Announce Fourth Quarter and Full-Year 2019 Results on February 26, 2020
2020-01-13 00:00 ET
Cutera Announces Preliminary Financial Results for Fourth Quarter and Full-Year 2019
2019-12-03 01:00 ET
Cutera to Present at the Piper Jaffray 31st Annual Healthcare Conference
2019-11-18 13:00 ET
Cutera Appoints Fuad Ahmad as Interim CFO
2019-11-07 21:05 ET
Cutera Reports Third Quarter 2019 Financial Results
2019-10-22 20:05 ET
Cutera, Inc. to Announce Third Quarter 2019 Results
2019-09-12 20:00 ET
Cutera Receives Additional Approval from Health Canada for its truSculpt® iD Body Sculpting Technology
2019-09-09 12:30 ET
Cutera to Present at Upcoming Investor Conferences
2019-04-18 20:05 ET
Cutera, Inc. to Announce First Quarter 2019 Results
2019-04-18 00:00 ET
Cutera Announces Regulatory Approval of Secret™ RF Microneedling System in Canada

SEC forms

Show financial reports only

SEC form 8
2024-03-21 16:02 ET
Cutera reported for 2023 q4
SEC form 8
2024-03-21 16:02 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:34 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:34 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:31 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:31 ET
Cutera published news for 2023 q4
SEC form 10
2024-03-05 16:29 ET
Cutera reported for 2023 q3
SEC form 8
2024-03-05 16:18 ET
Cutera published news for 2023 q4
SEC form 8
2024-03-05 16:18 ET
Cutera published news for 2023 q4
SEC form 10
2024-03-05 00:00 ET
Cutera reported for 2023 q3
SEC form 8
2024-01-09 00:00 ET
Cutera published news for 2023 q4
SEC form 8
2024-01-09 00:00 ET
Cutera published news for 2023 q4
SEC form 8
2023-11-08 16:06 ET
Cutera published news for 2023 q3
SEC form 10
2023-08-09 16:39 ET
Cutera published news for 2023 q2
SEC form 10
2023-08-09 00:00 ET
Cutera published news for 2023 q2
SEC form 6
2023-08-08 16:07 ET
Cutera reported for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Cutera published news for 2023 q2
SEC form 6
2023-07-31 16:22 ET
Cutera published news for 2023 q2
SEC form 6
2023-07-17 16:08 ET
Cutera published news for 2023 q2
SEC form 6
2023-06-09 16:32 ET
Cutera published news for 2023 q1
SEC form 10
2023-05-10 00:00 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-20 08:26 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-17 08:37 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-13 17:02 ET
Cutera published news for 2023 q1
SEC form 6
2023-04-12 17:07 ET
Cutera published news for 2023 q1
SEC form 10
2023-04-07 17:08 ET
Cutera published news for 2022 q4
SEC form 6
2023-04-07 15:55 ET
Cutera published news for 2023 q1
SEC form 10
2023-04-07 00:00 ET
Cutera reported for 2022 q4
SEC form 6
2023-03-24 17:24 ET
Cutera published news for 2022 q4
SEC form 6
2023-03-16 16:05 ET
Cutera published news for 2022 q4
SEC form 6
2023-02-28 17:15 ET
Cutera published news for 2022 q4
SEC form 6
2023-02-28 16:07 ET
Cutera published news for 2022 q4
SEC form 8
2023-02-28 00:00 ET
Cutera reported for 2022 q4
SEC form 6
2023-01-09 08:34 ET
Cutera published news for 2022 q4
SEC form 8
2023-01-09 00:00 ET
Cutera published news for 2022 q4
SEC form 6
2022-12-12 16:06 ET
Cutera published news for 2022 q3
SEC form 6
2022-12-07 16:03 ET
Cutera published news for 2022 q3
SEC form 8
2022-12-07 00:00 ET
Cutera published news for 2022 q3
SEC form 6
2022-12-01 16:40 ET
Cutera published news for 2022 q3
SEC form 10
2022-11-09 16:21 ET
Cutera published news for 2022 q3
SEC form 10
2022-11-09 00:00 ET
Cutera reported for 2022 q3
SEC form 6
2022-11-03 16:14 ET
Cutera published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Cutera reported for 2022 q3
SEC form 6
2022-11-01 16:08 ET
Cutera published news for 2022 q3
SEC form 6
2022-09-23 17:43 ET
Cutera published news for 2022 q2
SEC form 10
2022-08-08 17:01 ET
Cutera published news for 2022 q2
SEC form 10
2022-08-08 00:00 ET
Cutera reported for 2022 q2
SEC form 6
2022-08-05 11:46 ET
Cutera published news for 2022 q2
SEC form 8
2022-08-05 00:00 ET
Cutera reported for 2022 q2
SEC form 6
2022-06-17 17:08 ET
Cutera published news for 2022 q1
SEC form 6
2022-05-31 16:43 ET
Cutera published news for 2022 q1
SEC form 6
2022-05-24 08:37 ET
Cutera published news for 2022 q1
SEC form 8
2022-05-24 00:00 ET
Cutera published news for 2022 q1
SEC form 10
2022-05-10 16:25 ET
Cutera published news for 2022 q1
SEC form 6
2022-05-10 16:22 ET
Cutera published news for 2022 q1
SEC form 8
2022-05-10 00:00 ET
Cutera reported for 2022 q1
SEC form 10
2022-05-10 00:00 ET
Cutera reported for 2022 q1
SEC form 6
2022-05-02 12:37 ET
Cutera published news for 2022 q1
SEC form 10
2022-03-01 16:39 ET
Cutera published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Cutera published news for 2021 q4
SEC form 6
2022-02-22 16:14 ET
Cutera published news for 2021 q4
SEC form 8
2022-02-22 00:00 ET
Cutera published news for 2021 q4
SEC form 6
2021-12-13 17:06 ET
Cutera published news for 2021 q3
SEC form 10
2021-11-04 16:52 ET
Cutera published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Cutera published news for 2021 q3
SEC form 6
2021-11-03 16:10 ET
Cutera published news for 2021 q3
SEC form 8
2021-11-03 00:00 ET
Cutera published news for 2021 q3
SEC form 10
2021-08-06 17:01 ET
Cutera published news for 2021 q2
SEC form 10
2021-08-06 00:00 ET
Cutera published news for 2021 q2
SEC form 6
2021-08-04 16:31 ET
Cutera published news for 2021 q2
SEC form 8
2021-08-04 00:00 ET
Cutera published news for 2021 q2
SEC form 6
2021-06-17 18:06 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-25 17:14 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-24 20:59 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-17 16:03 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-12 13:55 ET
Cutera published news for 2021 q1
SEC form 10
2021-05-10 06:04 ET
Cutera published news for 2021 q1
SEC form 10
2021-05-10 00:00 ET
Cutera published news for 2021 q1
SEC form 6
2021-05-05 16:21 ET
Cutera published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Cutera published news for 2021 q1
SEC form 6
2021-04-30 09:05 ET
Cutera published news for 2021 q1
SEC form 10
2021-03-23 12:45 ET
Cutera published news for 2020 q4
SEC form 6
2021-03-17 16:12 ET
Cutera published news for 2020 q4
SEC form 6
2021-03-09 16:32 ET
Cutera published news for 2020 q4
SEC form 6
2021-03-03 17:23 ET
Cutera published news for 2020 q4
SEC form 6
2021-02-17 17:11 ET
Cutera published news for 2020 q4
SEC form 10
2020-11-09 15:56 ET
Cutera published news for 2020 q3
SEC form 6
2020-11-04 17:15 ET
Cutera published news for 2020 q3